Project Grant R01DA064510
Award Date 9/15/25
Completion Date 5/31/30
Dollars Obligated $723K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- This $147,486 federal Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a mixed-methods study examining the predictors and outcomes of methadone and buprenorphine receipt during incarceration. The study will analyze a longitudinal database on health service use and outcomes among 4,558 incarcerated individuals who received these medications from 2016-2023 at a unified jail and prison system in the Northeast....
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), under the Drug Use and Addiction Research Programs (CFDA 93.279), will fund a study to optimize opioid use disorder (OUD) treatment in prisons. The key products and services to be delivered include: Validating a 2-item OUD screening tool and an 11-item diagnostic DSM-5 OUD symptom checklist adapted for use in prisons. This will involve validating these tools against...
- This federal Project Grant award from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health, will evaluate the benefits of a hand-held, automated, personalized oral liquid dispensing system for take-home methadone medication management for patients with opioid use disorder (OUD). The $326,410 award, with a performance period from June 1, 2025 to May 31, 2026, will support a clinical program delivered by Berkshire Biomedical Corporation. The project aims to...
- This federal Project Grant award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), will support a clinical research hub to study the implementation and impact of a Medicaid Inmate Exclusion Policy (MIEP) waiver in 4 Massachusetts county jails. The $1,600,955 award, effective from Sep 1, 2025 to May 31, 2030, will be administered by the University of Massachusetts. The research aims to understand how the MIEP waiver, which...
- This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), provides $194,903 to support research led by Dr. Ashish Thakrar at the University of Pennsylvania. The goal is to rigorously develop and evaluate a "loading dose" approach to initiating methadone treatment for hospitalized patients with opioid use disorder who are using the synthetic opioid fentanyl. This research aims to improve outcomes for...
- This Project Grant award from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) provides $187,023 to Baystate Medical Center, Inc. in Massachusetts. The purpose is to conduct a mixed-methods study to determine the impact of the state's Behavioral Health Supports for Justice-Involved Individuals (BH-JI) program on healthcare utilization, costs, and overdose outcomes for individuals with opioid use disorder (OUD) upon release from...
- This Project Grant award of $783,300 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will fund a research study titled "Informing Best Practices for Substance-Use Treatment with Real-World Evidence for People with Opioid Use Disorder and HIV (STRONG)". The study will be conducted by The Johns Hopkins University in Maryland and aims to comprehensively characterize opioid use disorder (OUD) treatment, co-occurring substance use and...
- The National Institute on Drug Abuse (NIDA), under CFDA Program 93.279 - Drug Use and Addiction Research Programs, awarded a $1,548,605 Project Grant to the University of Massachusetts Medical School (UMMS) to test the effectiveness of the Jail ECHO Operations, Planning, and Strategy (J-ECHO OPS) implementation strategy to increase access to Medication for Opioid Use Disorder (MOUD) in rural jails. The study, titled "Improving Jail Response to the Overdose Crisis: A Hybrid Trial of Jail...
- This Project Grant award of $2,332,500.00 from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to transform systems of care in Washington state prisons to better address HIV, HIV risk, and substance use disorders. The key products and services to be delivered include: Building the foundation for a "prison learning health system" to improve the quality, efficiency, and reach of HIV treatment, HIV prevention, and...
- This Project Grant award of $182,187 from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) supports research to characterize spatial access to Medications for Opioid Use Disorder (MOUD) and co-located mental health services, and determine their association with overdose mortality and MOUD treatment uptake and retention. The research will be conducted by The Johns Hopkins University over the project period from August 1, 2025 to July 31, 2030. The...